Home

Kakas Zacskó Lásd a rovarokat overall survival definition többcélú Marco Polo illékonyság

Survival analysis in hematologic malignancies: recommendations for  clinicians | Haematologica
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica

Extrapolation from Progression Free Survival to Overall Survival in  Oncology | PPT
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know

PPT - Overall Survival and Progression-Free Survival PowerPoint  Presentation - ID:4064400
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400

A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials |  Radiology: Imaging Cancer
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer

CDISC SDTM and ADaM for survival data - ppt download
CDISC SDTM and ADaM for survival data - ppt download

Basics of survival statistics for oncologists Mehta A, Sharma A - J Curr  Oncol
Basics of survival statistics for oncologists Mehta A, Sharma A - J Curr Oncol

A correlation analysis to assess event-free survival as a trial-level  surrogate for overall survival in early breast cancer - eClinicalMedicine
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine

Survival in oncology reimbursement decision-making | CMAR
Survival in oncology reimbursement decision-making | CMAR

Study of NSCLC, melanoma outcomes points to surrogacy between real-world  endpoints and clinical trial endpoints - The Cancer Letter
Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpoints - The Cancer Letter

Outcomes and endpoints in trials of cancer treatment: the past, present,  and future - The Lancet Oncology
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know

Estimating progression-free survival in patients with glioblastoma using  routinely collected data | Journal of Neuro-Oncology
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology

Progression-free survival and overall survival. Progression-free... |  Download Scientific Diagram
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram

Understanding the clinical trial process | This Is Living With Cancer |  Official Site
Understanding the clinical trial process | This Is Living With Cancer | Official Site

A) Overall survival (OS) from study entry of all eligible patients... |  Download Scientific Diagram
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram

Trina Slabiak
Trina Slabiak

Outcomes and endpoints in trials of cancer treatment: the past, present,  and future - The Lancet Oncology
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology

Event-free survival > Overall survival? - data analysis - Datamethods  Discussion Forum
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum

Characterizing the Feasibility and Performance of Real-World Tumor  Progression End Points and Their Association With Overall Survival in a  Large Advanced Non–Small-Cell Lung Cancer Data Set | JCO Clinical Cancer  Informatics
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set | JCO Clinical Cancer Informatics

Historical time to disease progression and progression‐free survival in  patients with recurrent/refractory neuroblastoma treated in the modern era  on Children's Oncology Group early‐phase trials - London - 2017 - Cancer -  Wiley
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology  white paper
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper

Disease Free Survival - an overview | ScienceDirect Topics
Disease Free Survival - an overview | ScienceDirect Topics

Are progression-free and disease-free survival the new gold standard for  cancer trials? | Cancer World Archive
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive

Margin status and survival outcomes after breast cancer conservation  surgery: prospectively registered systematic review and meta-analysis | The  BMJ
Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis | The BMJ

The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A  Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink